As we age, NAD+ levels decline in the brain and other organs, and this decrease in NAD+ is associated with various disease states including neurodegeneration and other age-related disease
While the body naturally produces glutathione, various factors can reduce its levels, necessitating supplementation
Patient Experience Data While large-scale clinical trials of specific compounded GLP-1 formulations haven't been conducted, there's a growing body of real-world patient experience data
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that slows stomach emptying and reduces appetite signals in the brain, helping patients achieve meaningful weight loss
This transparency ensures that potential users feel informed and confident, from application timelines to injection techniques to side-effect scenarios
We emphasize the balance between clinical efficacy and financial considerations